Transapical valve-in-valve replacement of a stenosed prosthetic mitral valve in a critically ill patient with cardiogenic shock: a case report

2018 ◽  
Vol 34 (S2) ◽  
pp. 190-194
Author(s):  
Subbarao Elapavaluru ◽  
Harper Podolsky ◽  
Victor Farah ◽  
David Lasorda ◽  
Stephen Bailey
Keyword(s):  
Case Report ◽  
Mitral Valve ◽  
Cardiogenic Shock ◽  
Critically Ill ◽  
Valve Replacement ◽  
Critically Ill Patient ◽  
Valve In Valve ◽  
Prosthetic Mitral Valve

Reversal of Ischemic Hepatitis after Cardiac Surgery under Cardiopulmonary Bypass: A Case Report

2020 ◽  
Vol 3 (2) ◽  
pp. 36-37
Author(s):  
Lokesh Shekher Jaiswal ◽  
Narendra Pandit ◽  
Jagat Narayan Prasad
Keyword(s):  
Cardiac Surgery ◽  
Case Report ◽  
Cardiopulmonary Bypass ◽  
Mitral Valve ◽  
Cardiogenic Shock ◽  
Valve Replacement ◽  
Fulminant Hepatic Failure ◽  
Hepatic Failure ◽  
Acute Hepatic Failure ◽  
Ischemic Hepatitis

Acute hepatic failure due to ischemic hepatitis is associated with high mortality. The safety of cardiopulmonary bypass in this setting is not fully described. Here we report a case of a 21-year-old female who developed an acute fulminant hepatic failure due to ischemic hepatitis following a cardiogenic shock. She underwent subsequent successful mitral valve replacement under cardiopulmonary bypass, thus providing an evidence of its safety in acute fulminant hepatic failure.

scholarly journals Pneumocystis and SARS-CoV-2 Co-Infection: A Case Report and Review of an Emerging Diagnostic Dilemma

2020 ◽  
Author(s):  
Carlos Rubiano ◽  
Kathleen Tompkins ◽  
Subhashini A Sellers ◽  
Brian Bramson ◽  
Joseph Eron ◽  
...  
Keyword(s):  
Case Report ◽  
Critically Ill ◽  
Therapeutic Strategies ◽  
Pneumocystis Jirovecii ◽  
Critically Ill Patient ◽  
Pneumocystis Jirovecii Pneumonia ◽  
Diagnostic Dilemma

Abstract We present a case of a critically ill patient with COVID-19 found to have AIDS and Pneumocystis jirovecii pneumonia (PCP). COVID-19 and PCP co-occurrence is increasingly reported and may complicate diagnostic and therapeutic strategies. Patients with severe COVID-19 should be screened for underlying immunocompromise and coinfections should be considered.

scholarly journals Nonepileptic Myoclonus in COVID-19: Case Report

2021 ◽  
pp. 194187442110043
Author(s):  
Henly Hewan ◽  
Annie Yang ◽  
Aparna Vaddiparti ◽  
Benison Keung
Keyword(s):  
Case Report ◽  
Critically Ill ◽  
Recovery Phase ◽  
Critically Ill Patient ◽  
High Dose ◽  
The Novel ◽  
Neurological Manifestations ◽  
Immune Mediated ◽  
Novel Coronavirus ◽  
Post Infectious

In late 2019, the novel coronavirus, SARS-CoV-2, and the disease it causes, COVID-19, was identified. Since then many different neurological manifestations of COVID-19 have been well reported. Movement abnormalities have been rarely described. We report here a critically ill patient with COVID-19 who developed generalized myoclonus during the recovery phase of the infection. Myoclonus was associated with cyclical fevers and decreased alertness. Movements were refractory to conventional anti-epileptic therapies. There was concern that myoclonus could be part of a post-infectious immune-mediated syndrome. The patient improved fully with a 4-day course of high-dose steroids. Our experience highlights a rare, generalized myoclonus syndrome associated with COVID-19 that may be immune-mediated and is responsive to treatment.

Sign in / Sign up

Export Citation Format

Share Document